"What do people living with HIV need to know most about COVID-19?" Dr. David Wohl of the UNC CFAR's Clinical Core recently spoke with POSITIVELY … Read More
UNC Center for AIDS Research
It's about a real-life response to AIDS - a fierce commitment to creating and translating knowledge that advances the fight against HIV & AIDS
COVID-19 AND HIV Q&A WITH DR. DAVID WOHL – Positively Aware Magazine
UNC listed in top HIV/AIDS institutions by cited research impact
Last month, Elsevier Press reviewed the research impact of universities and institutions in HIV research worldwide. The University of North Carolina … Read More
ViiV Healthcare, UNC-Chapel Hill announce renewal of HIV cure partnership
"This unique public-private collaboration provides funding for HIV Cure Center and Qura Therapeutics, the joint venture that brings academic and … Read More
UNC CFAR in the News
Dr. Ada Adimora receives Thomas Jefferson Award
Professor Ada Adimora is this year’s Thomas Jefferson Award recipient. A Sarah Graham Kenan Distinguished Professor in the School of Medicine and professor of epidemiology in the Gillings School of Global Public Health, Dr. Adimora’s research focuses on the epidemiology of STDs and HIV in woman and under-served populations in order to reduce transmission rates… Read More
“Fighting Infections: The Long Term View” – 2020 Richardson Lecture with Dr. Myron Cohen
Dr. Myron S. Cohen, MD, Associate Director of the UNC CFAR, presented the 2020 Richardson Lecture, “Fighting Infections: The Long Term View.” Dr. Cohen is the Yeargan-Bate Eminent Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina (UNC) at Chapel Hill. He serves as the associate vice chancellor for global… Read More
Expecting the unexpected
Carolina experts are leveraging 40 years of HIV research to find a treatment for COVID-19. The Well recently published an article detailing UNC’s expertise in the field of HIV research and how this has influenced the research response to COVID-19. CFAR Associate Director Dr. Myron Cohen notes, “HIV has taught us how to approach problems… Read More
‘Landmark’ study finds long-acting injectable drug highly effective in preventing HIV
Results from HPTN 083, a global large-scale study, show that the long-acting drug cabotegravir (CAB LA) is highly effective for prevention of HIV acquisition in cisgender men and transgender women. The study compares effectiveness of injections and oral tablets as pre-exposure prophylaxis (PrEP) and is the first large-scale clinical trial of a long-acting injectable drug… Read More
Lauren Brinkley-Rubinstein joins Bernie Sanders for virtual town hall, “Incarcerated in a Crisis”
Dr. Lauren Brinkley-Rubinstein, PhD, co-leader of the UNC CFAR NC CHEP Scientific Working Group, joined Bernie Sanders for a virtual town hall, “Incarcerated in a Crisis” on May 7, 2020. The guests discussed what needs to be done to protect the rights of the incarcerated in throughout the COVID-19 crisis.
